118 related articles for article (PubMed ID: 38261977)
1. METHYLATION-ASSOCIATED PATHWAYS IN MACULAR TELANGIECTASIA TYPE 2 AND OPHTHALMOLOGIC FINDINGS IN PATIENTS WITH GENETIC METHYLATION DISORDERS.
Pauleikhoff L; Wingert V; Grünert SC; Lange C; Hannibal L; Bucher F
Retina; 2024 Jun; 44(6):1052-1062. PubMed ID: 38261977
[TBL] [Abstract][Full Text] [Related]
2. Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography.
Toto L; Di Antonio L; Mastropasqua R; Mattei PA; Carpineto P; Borrelli E; Rispoli M; Lumbroso B; Mastropasqua L
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT268-76. PubMed ID: 27409482
[TBL] [Abstract][Full Text] [Related]
3. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.
Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628
[TBL] [Abstract][Full Text] [Related]
4. Retinal ganglion cells thinning in eyes with nonproliferative idiopathic macular telangiectasia type 2A.
Chhablani J; Rao HB; Begum VU; Jonnadulla GB; Goud A; Barteselli G
Invest Ophthalmol Vis Sci; 2015 Feb; 56(2):1416-22. PubMed ID: 25655800
[TBL] [Abstract][Full Text] [Related]
5. EARLY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS TO CONFIRM FELLOW EYE CHANGES IN ASYMMETRIC TYPE-2 MACULAR TELANGIECTASIA: A Case-Control Study (India Macular Telangiectasia Report 1).
Alex D; Giridhar A; Gopalakrishnan M; Manayath G; Amar S; Raman R; Sreenivasan R; Ayachit A; Sivaprasad S
Retina; 2021 Mar; 41(3):471-479. PubMed ID: 32804830
[TBL] [Abstract][Full Text] [Related]
6. FLUORESCENCE LIFETIME PATTERNS IN MACULAR TELANGIECTASIA TYPE 2.
Solberg Y; Dysli C; Wolf S; Zinkernagel MS
Retina; 2020 Jan; 40(1):99-108. PubMed ID: 30664123
[TBL] [Abstract][Full Text] [Related]
7. Swept source optical coherence tomography analysis of choroidal thickness in macular telangiectasia type 2: a case-control study.
Kumar V; Kumawat D; Kumar P
Graefes Arch Clin Exp Ophthalmol; 2019 Mar; 257(3):567-573. PubMed ID: 30560414
[TBL] [Abstract][Full Text] [Related]
8. Ocular manifestations of cobalamin C type methylmalonic aciduria with homocystinuria.
Fuchs LR; Robert M; Ingster-Moati I; Couette L; Dufier JL; de Lonlay P; Brodie SE
J AAPOS; 2012 Aug; 16(4):370-5. PubMed ID: 22929452
[TBL] [Abstract][Full Text] [Related]
9. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy.
Ooto S; Hangai M; Takayama K; Arakawa N; Tsujikawa A; Koizumi H; Oshima S; Yoshimura N
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5541-50. PubMed ID: 21642620
[TBL] [Abstract][Full Text] [Related]
10. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography.
Pauleikhoff D; Gunnemann F; Book M; Rothaus K
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1381-1392. PubMed ID: 31093765
[TBL] [Abstract][Full Text] [Related]
11. Demographic features of idiopathic macular telangiectasia in Japanese patients.
Maruko I; Iida T; Sugano Y; Ojima A; Oyamada H; Sekiryu T
Jpn J Ophthalmol; 2012 Mar; 56(2):152-8. PubMed ID: 22219035
[TBL] [Abstract][Full Text] [Related]
12. Retinal vascular density evaluated by optical coherence tomography angiography in macular telangiectasia type 2.
Dogan B; Erol MK; Akidan M; Suren E; Akar Y
Int Ophthalmol; 2019 Oct; 39(10):2245-2256. PubMed ID: 30607862
[TBL] [Abstract][Full Text] [Related]
13. Retinal crystals in type 2 idiopathic macular telangiectasia.
Sallo FB; Leung I; Chung M; Wolf-Schnurrbusch UE; Dubra A; Williams DR; Clemons T; Pauleikhoff D; Bird AC; Peto T;
Ophthalmology; 2011 Dec; 118(12):2461-7. PubMed ID: 21839520
[TBL] [Abstract][Full Text] [Related]
14. Anti-retinal IgG antibodies in patients with early and advanced type 2 macular telangiectasia.
McLenachan S; Balaratnasingam C; Heath Jeffery RC; Chen SC; Zhang D; Chan G; Dolz-Marco R; Bacci T; Lo J; Wiffen S; Yannuzzi LA; Chen FK
Exp Eye Res; 2022 May; 218():109024. PubMed ID: 35271830
[TBL] [Abstract][Full Text] [Related]
15. Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography.
Spaide RF; Klancnik JM; Cooney MJ
JAMA Ophthalmol; 2015 Jan; 133(1):66-73. PubMed ID: 25317692
[TBL] [Abstract][Full Text] [Related]
16. MACULAR TELANGIECTASIA TYPE 2: Acircularity Index and Quantitative Assessment of Foveal Avascular Zone Using Optical Coherence Tomography Angiography.
Ersoz MG; Hocaoglu M; Sayman Muslubas I; Arf S; Karacorlu M
Retina; 2020 Jun; 40(6):1132-1139. PubMed ID: 30893277
[TBL] [Abstract][Full Text] [Related]
17. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
Ayachit AG; Reddy LU; Joshi S; Ayachit GS
Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
[TBL] [Abstract][Full Text] [Related]
18. Does size of telangiectasia on optical coherence tomography angiography influence vision in eyes with type 2 macular telangiectasia?
Kelkar AS; Kelkar JA; Tidke S; Agarwal A; Bolisetty M; Kelkar S
Indian J Ophthalmol; 2021 Dec; 69(12):3570-3576. PubMed ID: 34826997
[TBL] [Abstract][Full Text] [Related]
19. Identification of genetic factors influencing metabolic dysregulation and retinal support for MacTel, a retinal disorder.
Bonelli R; Jackson VE; Prasad A; Munro JE; Farashi S; Heeren TFC; Pontikos N; Scheppke L; Friedlander M; ; Egan CA; Allikmets R; Ansell BRE; Bahlo M
Commun Biol; 2021 Mar; 4(1):274. PubMed ID: 33654266
[TBL] [Abstract][Full Text] [Related]
20. Genetic Penetrance of Macular Telangiectasia Type 2.
Ronquillo CC; Wegner K; Calvo CM; Bernstein PS
JAMA Ophthalmol; 2018 Oct; 136(10):1158-1163. PubMed ID: 30098143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
